Breast Cancer

A recent and rare look at long-term lung cancer survivors shows breathlessness among them is persistent and common.

The latest in cancer prevention, diagnosis & treatment.

Adherence to oral hormone therapy for breast cancer patients is important, but non-compliance, and its consequences, are just now being recognized.

PARP inhibitors continue to look “promising.”

For those weighing whether to get their BRCA mutation status checked, the potential promise of the PARP inhibitors shouldn’t tip the balance—yet.

Metformin, a drug commonly used in the treatment of type 2 diabetes, is showing promise in the treatment of certain types of hormone-stimulated cancers, such as breast cancer and prostate cancer.

Only a few years ago, Bevelle and Edwards would have automatically received the same treatment. Not so today.

A new chemotherapy drug, called eribulin, extended survival by two and a half months in patients with locally recurrent or metastatic breast cancer whose cancers continued to progress despite treatment with numerous other drugs.

Updates results from the STAR trial show Evista and tamoxifen have long-term breast cancer prevention effects.

Updates from the annual meeting of the American Society of Clinical Oncology.

A growing population of patients have emerged: long-term metastatic cancer survivors.

The latest in cancer prevention, diagnosis, and treatment.

Progress in lung cancer is likely to stem from targeted treatments.

Studies show exercise in lung cancer patients can improve survival and quality of life.

Early-stage colorectal cancer patients may benefit from a new test that predicts their risk of recurrence.

Updates from the American Society of Hematology meeting and the San Antonio Breast Cancer Symposium.

In the past, doctors advised breast cancer survivors with lymphedema to avoid heavy lifting because of the possibility of infection and symptom flare-ups, but a new study shows weight-lifting may actually be beneficial and help reduce lymphedema symptoms.

Two recent studies offer hope of enhancing both the effectiveness and safety of Herceptin, the drug that helped introduce the era of targeted therapy.

Guided imagery decreased stress and relieved anxiety in patients who used the technique before and after radiation therapy for breast cancer, according to a study presented during a poster session at the San Antonio Breast Cancer Symposium.

One of the most visible side effects of chemotherapy is hair loss—a problem so distressing that some patients refuse treatment to avoid going bald.Studies have suggested that cooling the scalp during and immediately after treatment may help reduce hair loss. When the skin is cold, less blood flows to hair follicles, reducing their exposure to the drugs. One product, the Penguin Cold Cap System (manufactured by Medical Specialties of California UK), is billed as preventing hair loss in 80 percent of patients.

Women diagnosed with breast cancer could lower their risk of recurrence by cutting back on alcohol consumption, a new analysis suggests. Obesity itself is known to raise the risk of breast cancer, but a study described Thursday suggests that, after diagnosis, women who are overweight may fare worse than their normal-weight peers.

Studies have shown that Avastin, an angiogenesis inhibitor, has delayed disease progression in breast cancer patients, but a survival benefit has yet to be seen.

Two Komen advocates talk about their work on the local and global scenes